SCHEMBL25933805

SCHEMBL25933805

CCC(=O)[C@@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@@]21C

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 9/20 0.84
LMNA P02545 9/20 0.84
ALDH1A1 P00352 6/20 0.84
MAPT P10636 6/20 0.84
SMN1; SMN2 Q16637 5/20 0.84
MAPK1 P28482 4/20 0.84
SHBG P04278 4/20 0.84
SERPINA6 P08185 4/20 0.84
HSD17B10 Q99714 4/20 0.84
ABCB11 O95342 2/20 0.84
TSHR P16473 5/20 0.78
NR3C1 P04150 5/20 0.78
PGR P06401 5/20 0.78
AR P10275 4/20 0.78
CYP2C9 P11712 3/20 0.78
NR1I2 O75469 3/20 0.78
GPBAR1 Q8TDU6 3/20 0.78
SIGMAR1 Q99720 3/20 0.78
HIF1A Q16665 2/20 0.78
MEN1 O00255 2/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2169764 1.00 CYP3A4 (0.84) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
Desoxycorticosterone SCHEMBL25773308 0.91 LMNA (1.00) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
Desoxycorticosterone SCHEMBL4065 0.91 LMNA (1.00) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
Desoxycorticosterone SCHEMBL28269906 0.91 LMNA (1.00) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
Desoxycorticosterone SCHEMBL13752803 0.91 LMNA (1.00) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
Desoxycorticosterone SCHEMBL15763287 0.91 LMNA (1.00) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
Desoxycorticosterone SCHEMBL18891475 0.91 LMNA (1.00) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
Desoxycorticosterone SCHEMBL21243062 0.91 LMNA (1.00) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL22732246 0.91 LMNA (0.84) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
Desoxycorticosterone SCHEMBL4066 0.91 LMNA (1.00) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230250131-A1 HYDROXYSTEROID COMPOUNDS EPIRIUM BIO INC (US) 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230250131-A1 HYDROXYSTEROID COMPOUNDS HSD3B2, HSD11B1, HSD3B1 CYP3A4 132/4885LMNA 2148/4885ALDH1A1 1405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.